1-1 of 1
Keywords: 2nd-line therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Experience with Temsirolimus in 2nd-, 3rd- and 4th-Line Therapy for Metastatic Renal Cell Cancer: Good Clinical Response

Available to Purchase
Subject Area:
Further Areas
Timur Hasan Kuru, Johannes Huber, Gencay Hatiboglu, Nina Wagener, Sascha Pahernik, Boris Hadaschik, Markus Hohenfellner
Journal: Urologia Internationalis
Urol Int (2011) 86 (3): 256–260.
https://doi.org/10.1159/000322545
Published Online: 25 January 2011
... not be underestimated. Metastatic renal cell carcinoma 2nd-line therapy Pneumonitis Temsirolimus 23 09 2010 11 03 2010 25 1 2011 Urologia Internationalis Original Paper Urol Int 2011;86:256 260 DOI: 10.1159/000322545 Received: September 23, 2010 Accepted: November 3, 2010 Published online...
View article titled, Initial Experience with Temsirolimus in 2nd-, 3rd- and 4th-Line Therapy for Metastatic Renal Cell Cancer: Good Clinical Response
Open the PDF for Initial Experience with Temsirolimus in 2nd-, 3rd- and 4th-Line Therapy for Metastatic Renal Cell Cancer: Good Clinical Response in another window